These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32264066)
1. Dual-responsive core-crosslinked polyphosphoester-based nanoparticles for pH/redox-triggered anticancer drug delivery. Sun Y; Du X; He J; Hu J; Zhang M; Ni P J Mater Chem B; 2017 May; 5(20):3771-3782. PubMed ID: 32264066 [TBL] [Abstract][Full Text] [Related]
2. Dual-Responsive Polyphosphoester-Doxorubicin Prodrug Containing a Diselenide Bond: Synthesis, Characterization, and Drug Delivery. Ma G; Liu J; He J; Zhang M; Ni P ACS Biomater Sci Eng; 2018 Jul; 4(7):2443-2452. PubMed ID: 33435108 [TBL] [Abstract][Full Text] [Related]
3. A biodegradable polyphosphoester-functionalized poly(disulfide) nanocarrier for reduction-triggered intracellular drug delivery. Ju P; Hu J; Li F; Cao Y; Li L; Shi D; Hao Y; Zhang M; He J; Ni P J Mater Chem B; 2018 Nov; 6(44):7263-7273. PubMed ID: 32254638 [TBL] [Abstract][Full Text] [Related]
4. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
5. One-Pot Synthesis of pH/Redox Responsive Polymeric Prodrug and Fabrication of Shell Cross-Linked Prodrug Micelles for Antitumor Drug Transportation. Li L; Li D; Zhang M; He J; Liu J; Ni P Bioconjug Chem; 2018 Aug; 29(8):2806-2817. PubMed ID: 30005157 [TBL] [Abstract][Full Text] [Related]
6. Glucose-Sensitive Core-Cross-Linked Nanoparticles Constructed with Polyphosphoester Diblock Copolymer for Controlling Insulin Delivery. Li H; Zhou R; He J; Zhang M; Liu J; Sun X; Ni P Bioconjug Chem; 2021 Sep; 32(9):2095-2107. PubMed ID: 34469130 [TBL] [Abstract][Full Text] [Related]
7. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin. Yang S; Tang Z; Zhang D; Deng M; Chen X Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292 [TBL] [Abstract][Full Text] [Related]
8. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery. Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060 [TBL] [Abstract][Full Text] [Related]
9. A synergistic polyphosphoester-based co-delivery system of the anticancer drug doxorubicin and the tumor suppressor gene p53 for lung cancer therapy. Liu J; He J; Zhang M; Xu G; Ni P J Mater Chem B; 2018 May; 6(20):3262-3273. PubMed ID: 32254384 [TBL] [Abstract][Full Text] [Related]
10. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery. Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767 [TBL] [Abstract][Full Text] [Related]
11. Folate-Conjugated Polyphosphoester with Reversible Cross-Linkage and Reduction Sensitivity for Drug Delivery. Cao Y; He J; Liu J; Zhang M; Ni P ACS Appl Mater Interfaces; 2018 Mar; 10(9):7811-7820. PubMed ID: 29431989 [TBL] [Abstract][Full Text] [Related]
12. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845 [TBL] [Abstract][Full Text] [Related]
13. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery. Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122 [TBL] [Abstract][Full Text] [Related]
14. Polymer-Doxorubicin Prodrug with Biocompatibility, pH Response, and Main Chain Breakability Prepared by Catalyst-Free Click Reaction. Li D; Song Y; He J; Zhang M; Ni P ACS Biomater Sci Eng; 2019 May; 5(5):2307-2315. PubMed ID: 33405781 [TBL] [Abstract][Full Text] [Related]
15. A CD326 monoclonal antibody modified core cross-linked curcumin-polyphosphoester prodrug for targeted delivery and cancer treatment. Li H; Zhang M; He J; Liu J; Sun X; Ni P J Mater Chem B; 2023 Oct; 11(39):9467-9477. PubMed ID: 37782068 [TBL] [Abstract][Full Text] [Related]
16. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666 [TBL] [Abstract][Full Text] [Related]
17. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of intracellular reduction-sensitive amphiphilic polyethyleneimine and poly(ε-caprolactone) graft copolymer for on-demand release of doxorubicin and p53 plasmid DNA. Davoodi P; Srinivasan MP; Wang CH Acta Biomater; 2016 Jul; 39():79-93. PubMed ID: 27154500 [TBL] [Abstract][Full Text] [Related]
19. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy. Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147 [TBL] [Abstract][Full Text] [Related]
20. Fabrication of redox-responsive doxorubicin and paclitaxel prodrug nanoparticles with microfluidics for selective cancer therapy. Ma X; Özliseli E; Zhang Y; Pan G; Wang D; Zhang H Biomater Sci; 2019 Jan; 7(2):634-644. PubMed ID: 30534690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]